Nurix Therapeutics to Participate in Upcoming Investor Conference
Nurix Therapeutics, a clinical-stage biopharmaceutical company specializing in targeted protein degradation medicines, announced that CEO Arthur Sands will participate in a fireside chat at the upcoming Needham Virtual Healthcare Conference. The company highlighted its current clinical and preclinical pipeline, including collaborations with major p…